|
2022
|
Invention
|
Formulations for nasal covid-19 vaccines. The invention relates to a SARS-CoV-2 spike protein, an... |
|
|
P/S
|
Pharmaceutical products and preparations for prevention, treatment and immune therapy and combina... |
|
|
P/S
|
Pharmaceutical products and preparations; vaccines and
medicines; all the aforementioned product... |
|
|
Invention
|
Modified hexa-acylated neisserial lps.
The present invention relates to neisserial LPS having a ... |
|
2021
|
Invention
|
Ompa mutations enhance omv production in bordetella pertussis.
The invention pertains to a mutan... |
|
|
Invention
|
Ompa mutations enhance omv production in bordetella pertussis. BordetellaBordetellaBordetellaBord... |
|
|
P/S
|
Pharmaceutical products and preparations; vaccines and
medicines. Apparatus and containers for t... |
|
|
Invention
|
Click omvs.
The invention pertains to a complex of an OMV, a vertebrate antimicrobial peptide (A... |
|
|
Invention
|
Click omvs. The invention pertains to a complex of an OMV, a vertebrate antimicrobial peptide (AM... |
|
2019
|
Invention
|
Surface display of antigens on gram-negative outer membrane vesicles. The present invention relat... |
|
2018
|
Invention
|
Process for producing outer membrane vesicles. The present invention relates to the fields of med... |
|
|
Invention
|
Bordetella vaccines comprising lps with reduced reactogenicity. Bordetella cell of the invention ... |
|
2017
|
Invention
|
Methods and compositions for stabilizing dried biological materials. The present invention relate... |
|
|
Invention
|
Modified tetra-acylated neisserial lps. The present invention relates to neisserial LPS having a ... |
|
|
Invention
|
Modified hexa-acylated neisserial lps. The present invention relates to neisserial LPS having a h... |
|
2016
|
Invention
|
Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium. Th... |
|
2015
|
Invention
|
Respiratory syncytial virus with a genomic deficiency complemented in trans. The invention relate... |
|
2014
|
Invention
|
Methods for the prevention of aggregation of viral components. The present invention relates to a... |
|
|
P/S
|
[Pharmaceutical products and preparations for prevention, treatment and immune therapy and combin... |
|
2013
|
P/S
|
Pharmaceutical products and preparations for prevention, treatment and immune therapy of infectio... |
|
2001
|
P/S
|
Pharmaceutical preparations, including vaccines. |
|
2000
|
Invention
|
Mutants of gram negative mucosal bacteria and application thereof in vaccines. N. meningitidis op... |
|
1995
|
Invention
|
Pneumolysin mutants and pneumococcal vaccines made therefrom. Mutants of pneumolysin that are non... |
